PDS Biotechnology Corporation

Research PDS Biotechnology Corporation (PDSB) on Bullrun: market cap USD 50.18M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPDSB
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 50.18M
• Financial periodFY2025
• Net income-USD 34.50M
• Free cash flow-USD 27.75M

Valuation Snapshot

latest market cap is USD 50.18M.

About PDS Biotechnology Corporation

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101, a Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers.

Frequently asked questions

What is PDS Biotechnology Corporation's market cap?

PDS Biotechnology Corporation's market capitalization is USD 50.18M.

What does PDS Biotechnology Corporation do?

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.